Gastric Cancer: 288 Real Stories

288 stories match gastric cancer. 206 of them mention surgery.

A patient, who was diagnosed with Gastric CancerGastric Cancer

Large Gastric Carcinosarcoma Removed With Partial Stomach Surgery

Patient Info: Anonymized, Female

Biomarkers: Pancytokeratin positive; CK7 positive; vimentin positive; DOG-1 negative; CD117 negative; calretinin negative; SMA negative; S100 negative

She recovered without postoperative complications and remained asymptomatic for 3 months. At 6 months, she died after intensive-care admission for a lower urinary tract infection and urosepsis.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage IV Gastric AdenocarcinomaGastric Cancer

Stage IV Stomach Cancer With Recurrent Bowel Obstruction and Severe Pain

Patient Info: Anonymized, Male | Stage IV

Metastatic Site: splenic flexure|perineal nodule

He remained on palliative treatment more than 6 months after the described admission and had 3 additional hospitalizations for recurrent partial small-bowel obstruction, all managed without surgery.

PubMed Central
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Gastric AdenocarcinomaGastric Cancer

Adrenal metastasis from gastric cancer causing adrenal insufficiency

Patient Info: Anonymized, male, 60s | Stage IV

Biomarkers: HER2-negative, PD-L1-negative

Metastatic Site: right adrenal gland

More than 17 months after the metastatic relapse, he was clinically well with no radiological or biochemical signs of active cancer apart from the residual right adrenal lesion.

PubMed Central
OutcomeStable Disease
Sagan, who was diagnosed with Stage II Gastric CancerGastric Cancer

Stage II Gastric Cancer: Sagan's Patient Story

Patient Info: Sagan | Stage II

Sagan reported completing cancer treatment and continued taking medicines for treatment-related symptoms while focusing on recovery.

Our Cancer Stories
OutcomeNot reported
Angel, who was diagnosed with Stage IV Gastric AdenocarcinomaGastric Cancer

Stage IV Gastric Adenocarcinoma: Angel's Survivor Story

Patient Info: Angel | Stage IV

Angel was declared cancer-free in August 2024 and described being NED within 1 year of the Stage IV gastric cancer diagnosis.

Our Cancer Stories
OutcomeCancer-Free / NED
Cece, who was diagnosed with Stage II Gastric AdenocarcinomaGastric Cancer

Stage II Gastric Adenocarcinoma: Cece's Survivor Story

Patient Info: Cece, 40s | Stage II

Cece reported being cancer-free from April 2024 after total gastrectomy and lymph node removal, while continuing to manage major long-term effects of living without a stomach.

Our Cancer Stories
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage I Gastric AdenocarcinomaGastric Cancer

A suspected gastric cancer recurrence that proved to be a desmoid tumor

Patient Info: Anonymized, male, 60s | Stage I

More than 2 years after gastrectomy, a suspicious abdominal mass proved to be a desmoid tumor rather than recurrent gastric cancer. No gastric cancer recurrence was identified.

PubMed Central
OutcomeCancer-Free / NED
Rachel, who was diagnosed with Stage IV Gastric CancerGastric Cancer

Stage IV Gastric Cancer: Rachel's Patient Story

Patient Info: Rachel Orth, Female, Under 40 | Stage IV

Rachel previously reported stable metastatic gastric cancer while receiving treatment on a phase I clinical trial. She died in June 2025.

AACR
OutcomeIn Memory
Alan, who was diagnosed with Gastric CancerGastric Cancer

Gastric Cancer: Alan's Patient Story

Patient Info: Alan Salm, Male, 50s | Stage Metastatic/Advanced

Alan died from stomach cancer on May 5, 2021, 1 month before his 53rd birthday.

No Stomach For Cancer
OutcomeIn Memory
A patient, who was diagnosed with Stage II Gastric AdenocarcinomaGastric Cancer

Stage IIB Gastric Cancer With a Gastric-Wall Abscess

Patient Info: Anonymized, Female, 70+ | Stage II

Biomarkers: Synaptophysin positive; CD56 negative; chromogranin A negative; SALL4 negative

The tumor and abscess were removed completely, and no lymph-node metastases were found. She remained disease-free through 22 months of follow-up.

PubMed Central
OutcomeCancer-Free / NED